Fh-partners.com

Neurent Medical Receives FDA Clearance for NEUROMARK™, a …

WebProprietary NEUROMARK™ system is the first in-office treatment indicated to disrupt symptom-causing nerve tissue for Chronic Rhinitis patients. Neurent Medical, a …

Actived: 2 days ago

URL: https://www.fh-partners.com/news-entries/2021/11/18/neurent-medical-receives-fda-clearance-for-neuromark-a-novel-multi-point-nerve-disruption-treatment-for-chronic-rhinitis

Vivasure Medical Announces FDA IDE Approval to Initiate U.S.

WebPivotal study expected to be completed by year-end 2023 and set the stage for commercialization of PerQseal® system for large hole vessel closure Company …

Category: Health Go Health

Vivasure Medical — News Entries — Fountain Healthcare …

WebVivasure Medical® (“Vivasure” or the “Company”), a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced the …

Category: Medical Go Health

Fountain Healthcare Partners

WebOur years of experience help entrepreneurs grow smartly, mitigate risk and expand impact. We invest the majority of our fund in Europe and the rest in the US. We bridge the …

Category: Health Go Health

Medical Microinstruments Secures $75M to Advance Robotic …

WebSeries B financing will accelerate clinical trials and global commercialization of the company’s Symani® Surgical System. Medical Microinstruments, Inc. (MMI), a …

Category: Medical Go Health

Team — Fountain Healthcare Partners

WebTania is a PhD biochemist by training. Prior to joining Fountain, she led the Healthcare team at the Gerson Lehrman Group gaining broad industry exposure across pharmaceutical, …

Category: Health Go Health

Vivasure Medical Announces Series D Financing to Advance …

WebFunds will support clinical development and regulatory approval of fully absorbable percutaneous closure devices for large-bore vessels. Vivasure Medical® …

Category: Medical Go Health

Neuromod Establishes U.S. Presence, Adds Local Leadership

WebNeuromod Devices Ltd, the Irish medical device company specialising in the treatment of tinnitus, has announced the establishment of Neuromod USA Inc., a …

Category: Medical Go Health

Portfolio — Fountain Healthcare Partners

WebKaNDy Therapeutics was a UK based clinical-stage company focused on developing NT-814, a first-in-class, once daily, dual mechanism neurokinin-1,3 receptor antagonist. The …

Category: Health Go Health

News — Fountain Healthcare Partners

WebJan 8, 2024. Inotrem Successfully Reaches Agreement with the FDA for a Phase 3 Registration Trial for Nangibotide in Septic Shock. Jan 8, 2024. Calypso Enters into …

Category: Health Go Health